Expertise in
8
conditions

Dr. Vimal Prajapati

Pediatrics
Boston Children's Hospital
300 Longwood Ave, 
Boston, MA 
Expertise in
8
conditions
Boston Children's Hospital
300 Longwood Ave, 
Boston, MA 

Overview

Vimal Prajapati is a Pediatrics provider in Boston, Massachusetts. Dr. Prajapati is highly rated in 8 conditions, according to our data. His top areas of expertise are Plaque Psoriasis, Atopic Dermatitis, Generalized Pustular Psoriasis (GPP), and Psoriasis.

His clinical research consists of co-authoring 115 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Pediatrics

Licenses

Pediatric Dermatology in MA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Boston Children's Hospital
300 Longwood Ave, Boston, MA 02115

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: September 18, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo-controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: September 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

115 Total Publications

OX40 Ligand Inhibitors for Moderate-to-Severe Atopic Dermatitis: A Review of Phase II Clinical Trial Data.
OX40 Ligand Inhibitors for Moderate-to-Severe Atopic Dermatitis: A Review of Phase II Clinical Trial Data.
Journal: Skin therapy letter
Published: December 10, 2025
Similar Doctors
Expertise in
43
conditions
Dr. Jurriaan M. Peters
Pediatrics
Expertise in
43
conditions
Dr. Jurriaan M. Peters
Pediatrics

C H Neurology Foundation Inc

300 Longwood Ave, 
Boston, MA 
 (0.1 miles away)
617-355-6000
Languages Spoken:
English
See accepted insurances

Jurriaan Peters is a Pediatrics provider in Boston, Massachusetts. Dr. Peters is highly rated in 43 conditions, according to our data. His top areas of expertise are Tuberous Sclerosis Complex, Tuberous Sclerosis, Cortical Dysplasia, Seizures, and Prostatectomy.

Expertise in
41
conditions
Dr. Phillip L. Pearl
Pediatrics
Expertise in
41
conditions
Dr. Phillip L. Pearl
Pediatrics

C H Neurology Foundation Inc

300 Longwood Ave, 
Boston, MA 
 (0.1 miles away)
617-355-6000
Languages Spoken:
English
See accepted insurances

Phillip Pearl is a Pediatrics provider in Boston, Massachusetts. Dr. Pearl is highly rated in 41 conditions, according to our data. His top areas of expertise are Succinic Semialdehyde Dehydrogenase Deficiency, Epilepsy, Epilepsy in Children, and Seizures.

Expertise in
36
conditions
Dr. Audrey Dionne
Pediatrics
Expertise in
36
conditions
Dr. Audrey Dionne
Pediatrics

Department Of Cardiology

300 Longwood Ave, 
Boston, MA 
 (0.1 miles away)
617-355-2079
Languages Spoken:
English
See accepted insurances

Audrey Dionne is a Pediatrics provider in Boston, Massachusetts. Dr. Dionne is highly rated in 36 conditions, according to our data. Her top areas of expertise are Multisystem Inflammatory Syndrome in Children (MIS-C), Kawasaki Disease, Coronary Artery Aneurysm, Cardiac Ablation, and Heart Bypass Surgery.

Frequently Asked Questions about Dr. Vimal Prajapati

How do I make an appointment with Dr. Vimal Prajapati?

You can book an appointment with Dr. Vimal Prajapati by calling their office at 617-580-1982. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Vimal Prajapati a top-rated expert for Plaque Psoriasis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Vimal Prajapati is classified as an Elite expert for Plaque Psoriasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Vimal Prajapati specialize in?

While Dr. Vimal Prajapati is a Pediatrics, they have specific expertise in Plaque Psoriasis, Atopic Dermatitis, and Generalized Pustular Psoriasis (GPP). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Vimal Prajapati participate in research or clinical trials?

Yes. Dr. Vimal Prajapati has published 115 articles and abstracts on conditions like Plaque Psoriasis. You can view a list of Dr. Vimal Prajapati's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Prajapati's expertise for a condition
ConditionClose
View All 13 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile